Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. PPM Ventures and Triton – acquisition of Pharmacia Diagnostics
Mandate

PPM Ventures and Triton – acquisition of Pharmacia Diagnostics

May 12, 2005

Triton, the European private equity firm, and PPM Ventures Ltd, the private equity business within Prudential Corporation plc, the UK financial services group, has agreed to acquire Pharmacia Diagnostics AB, the Swedish based in-vitro allergy and autoimmune diagnostic testing business of Pfizer Inc, the US-based health care company, for USD 575m.

Vinge acted for Triton and PPM Ventures Ltd.

Johan Cederlund, Christina Kokko (responsible partners)
Sara Mindus (associate)

Related

Vinge advises Anyfin with application to conduct financing business

 Vinge has, together with PwC, advised Anyfin with regulatory advice in connection with Anyfin’s application to conduct financing business pursuant to the Banking and Financing Business Act (2004:297). The Swedish Financial Supervisory Authority granted the license on 17 June 2025.
June 25, 2025

Vinge advises Lantmännen in connection with the divestment of Swecon to Volvo Construction Equipment

Lantmännen Ek för has signed an agreement to divest Swecon to Volvo Construction Equipment (Volvo CE). Volvo CE will pay SEK 7 billion for the acquisition. The transaction is subject to regulatory approvals and is expected to be completed during the second half of 2025.
June 25, 2025

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025